ATE118350T1 - Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung. - Google Patents

Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.

Info

Publication number
ATE118350T1
ATE118350T1 AT89906285T AT89906285T ATE118350T1 AT E118350 T1 ATE118350 T1 AT E118350T1 AT 89906285 T AT89906285 T AT 89906285T AT 89906285 T AT89906285 T AT 89906285T AT E118350 T1 ATE118350 T1 AT E118350T1
Authority
AT
Austria
Prior art keywords
methods
compositions
wound healing
skin diseases
treating skin
Prior art date
Application number
AT89906285T
Other languages
English (en)
Inventor
John Rothman
Philip A Band
Original Assignee
Morris John Co Inc
Philip A Band
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morris John Co Inc, Philip A Band filed Critical Morris John Co Inc
Application granted granted Critical
Publication of ATE118350T1 publication Critical patent/ATE118350T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT89906285T 1988-07-22 1989-03-03 Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung. ATE118350T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22316788A 1988-07-22 1988-07-22

Publications (1)

Publication Number Publication Date
ATE118350T1 true ATE118350T1 (de) 1995-03-15

Family

ID=22835341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89906285T ATE118350T1 (de) 1988-07-22 1989-03-03 Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.

Country Status (7)

Country Link
EP (1) EP0425507B1 (de)
JP (1) JPH03506024A (de)
KR (1) KR900701303A (de)
AT (1) ATE118350T1 (de)
AU (1) AU3687489A (de)
DE (1) DE68921209T2 (de)
WO (1) WO1990000899A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
GB9211736D0 (en) * 1992-06-03 1992-07-15 Univ Cardiff Allergic treatment
GB2267437B (en) * 1992-06-03 1997-01-22 Univ Cardiff Treatment of allergic contact dermatitis
CZ257296A3 (en) * 1994-03-03 1997-01-15 Procter & Gamble Acne suppressant for external application
IT1278052B1 (it) * 1995-03-14 1997-11-17 Mendes Srl Uso delle immunoglobuline della classe g, in particolare delle immunoglobuline per uso endovenoso o per uso intramuscolare, per
IL120943A (en) * 1997-05-29 2004-03-28 Univ Ben Gurion A system for administering drugs through the skin
US6667052B2 (en) * 1997-05-29 2003-12-23 Ben Gurion University Of The Negev Research And Development Authority Transdermal delivery system
US6071541A (en) * 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
US6673374B2 (en) 1998-07-31 2004-01-06 Howard Murad Pharmaceutical compositions and methods for managing skin conditions
EP1478328B1 (de) * 2002-01-28 2013-06-05 Keraplast Technologies Ltd. Bioaktive keratinpeptide
WO2007110924A1 (ja) * 2006-03-28 2007-10-04 Tohoku University 揮発性成分を用いた酸化防止方法
CA2946568C (en) 2014-04-21 2020-07-07 Aclaris Therapeutics, Inc. Peroxide formulations and methods and applicators for using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195095A (en) * 1969-04-04 1980-03-25 Sheffner Aaron L Topical application of thioglycolic acid in the treatment of dermatological conditions
US3842848A (en) * 1971-05-27 1974-10-22 Wilson Sinclair Co Keratin polypeptide hydrolyzates as hair treating agents
JPS5716810A (en) * 1980-07-02 1982-01-28 Yoshio Murai Cosmetic
FR2522657B1 (fr) * 1982-03-05 1985-07-12 Oreal Composition de traitement d'un substrat keratinique comportant des proteines chimiquement modifiees et procede de preparation desdites proteines
US4438102A (en) * 1982-08-10 1984-03-20 Ciro's Touch, Ltd. Method of promoting tissue growth

Also Published As

Publication number Publication date
EP0425507A4 (en) 1991-07-03
WO1990000899A1 (en) 1990-02-08
AU3687489A (en) 1990-02-19
DE68921209D1 (de) 1995-03-23
KR900701303A (ko) 1990-12-01
EP0425507B1 (de) 1995-02-15
JPH03506024A (ja) 1991-12-26
DE68921209T2 (de) 1995-10-19
EP0425507A1 (de) 1991-05-08

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
ATE118350T1 (de) Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE3878866D1 (de) 3-indolpyruvsaeure-derivate und deren verwendung als arznemittel.
EP0206529A3 (de) Behandlung oraler Krankheiten
DE69411424D1 (de) Zur Behandlung von Erkrankungen des Zentralnervensystems verwendbare Benzimidazole
BR9712648A (pt) Uso de complexos para a preparação de composições para o tratamento de pele sensìvel,processo de preparaçào e composições hipo-alergênicas
ES2038609T3 (es) 4,5-dihidroisoxazol, 3,5 disustituido como inhibidores de transglutaminasa.
ATE245452T1 (de) Hyaluronatlyase als penetrationsförderer in topischen mitteln
ATE138567T1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ES2187667T3 (es) Uso de relaxina para estimular angiogenesis.
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
ATE284216T1 (de) Formulierungen und verfahren zur verminderung von hautirritationen
EP0767666A4 (de) Verfahren und präparate für die prophylaxe und therapie von mit endotoxin verbundenen zuständen
FI862609A0 (fi) Akne motverkande produkt.
ES2102097T3 (es) Acidos fenilalcan(quen)oicos con actividad antagonista del leucotrieno b4.
BR9106377A (pt) Composicao e processo para o tratamento topico de tecido lesado ou enfermo
ATE381327T1 (de) Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
ES2178405T3 (es) Uso de selegilina o de desmetilselegilina para tratar heridas, quemaduras y lesiones cutaneas.
ES2095578T3 (es) Composicion para el tratamiento de mastitis y metritis.
ES2075272T5 (es) Composiciones dermatologicas conteniendo acido cis-urocanico.
ES2102777T3 (es) Composiciones que contienen 8-hidroxiquinolina para el tratamiento de enfermedades hiperproliferativas de la piel.
MX164619B (es) Composicion para el tratamiento de lesiones cutaneas
NZ216519A (en) Polycyclic compounds and pharmaceutical compositions
ATE216589T1 (de) Neurotoxine zur behandlung von hauterkrankungen bei säugetieren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties